Thea Pharma GmbH secures contract for Pharmaceutical Products - Completion of a non -exclusive discount agreement according to Section 130a (8) SGB V for the active ingredient Latanoprost Timolol (exclusive forms of dosage as individual doses), ATC S01ED61 F D Z 010623 - 310525

Germany, May 13 -- Germany based Thea Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical Products - Completion of a non -exclusive discount agreement according to Section 130a (8) SGB V for the active ingredient Latanoprost Timolol (exclusive forms of dosage as individual doses), ATC S01ED61 F D Z 010623 - 310525. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....